nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC7A11—Rosuvastatin—atherosclerosis	0.411	0.532	CbGbCtD
Acetylcysteine—SLCO1B1—Ezetimibe—atherosclerosis	0.0679	0.0878	CbGbCtD
Acetylcysteine—SLCO1B1—Rosuvastatin—atherosclerosis	0.0679	0.0878	CbGbCtD
Acetylcysteine—SLCO1B1—Simvastatin—atherosclerosis	0.0631	0.0816	CbGbCtD
Acetylcysteine—SLCO1B1—Lovastatin—atherosclerosis	0.0617	0.0799	CbGbCtD
Acetylcysteine—SLCO1B1—Pravastatin—atherosclerosis	0.0617	0.0799	CbGbCtD
Acetylcysteine—SLC22A6—Pravastatin—atherosclerosis	0.0397	0.0514	CbGbCtD
Acetylcysteine—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00244	0.0366	CcSEcCtD
Acetylcysteine—Haemoptysis—Niacin—atherosclerosis	0.00194	0.0291	CcSEcCtD
Acetylcysteine—Feeling hot—Niacin—atherosclerosis	0.00183	0.0274	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00106	0.016	CcSEcCtD
Acetylcysteine—Face oedema—Niacin—atherosclerosis	0.001	0.0151	CcSEcCtD
Acetylcysteine—Pharyngitis—Rosuvastatin—atherosclerosis	0.000981	0.0148	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Pravastatin—atherosclerosis	0.000916	0.0138	CcSEcCtD
Acetylcysteine—Pharyngitis—Ezetimibe—atherosclerosis	0.000816	0.0123	CcSEcCtD
Acetylcysteine—Angioedema—Rosuvastatin—atherosclerosis	0.000786	0.0118	CcSEcCtD
Acetylcysteine—Stomatitis—Niacin—atherosclerosis	0.000781	0.0117	CcSEcCtD
Acetylcysteine—Flushing—Lovastatin—atherosclerosis	0.000778	0.0117	CcSEcCtD
Acetylcysteine—Sweating—Niacin—atherosclerosis	0.000768	0.0116	CcSEcCtD
Acetylcysteine—Flushing—Ezetimibe—atherosclerosis	0.000763	0.0115	CcSEcCtD
Acetylcysteine—Cough—Rosuvastatin—atherosclerosis	0.000751	0.0113	CcSEcCtD
Acetylcysteine—Angiopathy—Ezetimibe—atherosclerosis	0.000746	0.0112	CcSEcCtD
Acetylcysteine—Immune system disorder—Ezetimibe—atherosclerosis	0.000742	0.0112	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000741	0.0111	CcSEcCtD
Acetylcysteine—Flushing—Simvastatin—atherosclerosis	0.000727	0.0109	CcSEcCtD
Acetylcysteine—Erythema—Ezetimibe—atherosclerosis	0.000715	0.0108	CcSEcCtD
Acetylcysteine—Pharyngitis—Pravastatin—atherosclerosis	0.000703	0.0106	CcSEcCtD
Acetylcysteine—Erythema—Simvastatin—atherosclerosis	0.000682	0.0103	CcSEcCtD
Acetylcysteine—Flushing—Niacin—atherosclerosis	0.000668	0.01	CcSEcCtD
Acetylcysteine—Angioedema—Lovastatin—atherosclerosis	0.000666	0.01	CcSEcCtD
Acetylcysteine—Flushing—Pravastatin—atherosclerosis	0.000658	0.00989	CcSEcCtD
Acetylcysteine—Cardiac disorder—Pravastatin—atherosclerosis	0.000658	0.00989	CcSEcCtD
Acetylcysteine—Angioedema—Ezetimibe—atherosclerosis	0.000654	0.00983	CcSEcCtD
Acetylcysteine—Angiopathy—Niacin—atherosclerosis	0.000653	0.00982	CcSEcCtD
Acetylcysteine—Erythema—Niacin—atherosclerosis	0.000626	0.00942	CcSEcCtD
Acetylcysteine—Cough—Ezetimibe—atherosclerosis	0.000624	0.00938	CcSEcCtD
Acetylcysteine—Angioedema—Simvastatin—atherosclerosis	0.000623	0.00937	CcSEcCtD
Acetylcysteine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000618	0.0093	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000605	0.00909	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000595	0.00895	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000584	0.00878	CcSEcCtD
Acetylcysteine—Angioedema—Niacin—atherosclerosis	0.000572	0.00861	CcSEcCtD
Acetylcysteine—Skin disorder—Ezetimibe—atherosclerosis	0.000567	0.00853	CcSEcCtD
Acetylcysteine—Angioedema—Pravastatin—atherosclerosis	0.000564	0.00847	CcSEcCtD
Acetylcysteine—Syncope—Niacin—atherosclerosis	0.000562	0.00845	CcSEcCtD
Acetylcysteine—Urticaria—Rosuvastatin—atherosclerosis	0.000558	0.00839	CcSEcCtD
Acetylcysteine—Oedema—Simvastatin—atherosclerosis	0.000557	0.00837	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000557	0.00837	CcSEcCtD
Acetylcysteine—Loss of consciousness—Niacin—atherosclerosis	0.000551	0.00828	CcSEcCtD
Acetylcysteine—Cough—Niacin—atherosclerosis	0.000547	0.00822	CcSEcCtD
Acetylcysteine—Cough—Pravastatin—atherosclerosis	0.000538	0.00809	CcSEcCtD
Acetylcysteine—Dyspnoea—Lovastatin—atherosclerosis	0.000531	0.00798	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00053	0.00796	CcSEcCtD
Acetylcysteine—Dyspepsia—Lovastatin—atherosclerosis	0.000524	0.00788	CcSEcCtD
Acetylcysteine—Dyspnoea—Ezetimibe—atherosclerosis	0.000521	0.00783	CcSEcCtD
Acetylcysteine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000517	0.00778	CcSEcCtD
Acetylcysteine—Dyspepsia—Ezetimibe—atherosclerosis	0.000514	0.00773	CcSEcCtD
Acetylcysteine—Oedema—Niacin—atherosclerosis	0.000511	0.00769	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Niacin—atherosclerosis	0.000511	0.00769	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000504	0.00758	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000503	0.00757	CcSEcCtD
Acetylcysteine—Oedema—Pravastatin—atherosclerosis	0.000503	0.00757	CcSEcCtD
Acetylcysteine—Shock—Niacin—atherosclerosis	0.000503	0.00756	CcSEcCtD
Acetylcysteine—Tachycardia—Niacin—atherosclerosis	0.000499	0.0075	CcSEcCtD
Acetylcysteine—Pruritus—Rosuvastatin—atherosclerosis	0.000497	0.00747	CcSEcCtD
Acetylcysteine—Skin disorder—Niacin—atherosclerosis	0.000497	0.00747	CcSEcCtD
Acetylcysteine—Dyspnoea—Simvastatin—atherosclerosis	0.000496	0.00746	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Niacin—atherosclerosis	0.000494	0.00743	CcSEcCtD
Acetylcysteine—Dyspepsia—Simvastatin—atherosclerosis	0.00049	0.00737	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000487	0.00732	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000481	0.00723	CcSEcCtD
Acetylcysteine—Hypotension—Niacin—atherosclerosis	0.000478	0.00718	CcSEcCtD
Acetylcysteine—Urticaria—Lovastatin—atherosclerosis	0.000473	0.00711	CcSEcCtD
Acetylcysteine—Body temperature increased—Lovastatin—atherosclerosis	0.000471	0.00707	CcSEcCtD
Acetylcysteine—Dizziness—Rosuvastatin—atherosclerosis	0.000464	0.00698	CcSEcCtD
Acetylcysteine—Urticaria—Ezetimibe—atherosclerosis	0.000464	0.00697	CcSEcCtD
Acetylcysteine—Body temperature increased—Ezetimibe—atherosclerosis	0.000462	0.00694	CcSEcCtD
Acetylcysteine—Dyspnoea—Niacin—atherosclerosis	0.000456	0.00685	CcSEcCtD
Acetylcysteine—Somnolence—Niacin—atherosclerosis	0.000454	0.00683	CcSEcCtD
Acetylcysteine—Dyspepsia—Niacin—atherosclerosis	0.00045	0.00677	CcSEcCtD
Acetylcysteine—Dyspnoea—Pravastatin—atherosclerosis	0.000449	0.00675	CcSEcCtD
Acetylcysteine—Dyspepsia—Pravastatin—atherosclerosis	0.000443	0.00666	CcSEcCtD
Acetylcysteine—Rash—Rosuvastatin—atherosclerosis	0.000443	0.00666	CcSEcCtD
Acetylcysteine—Dermatitis—Rosuvastatin—atherosclerosis	0.000442	0.00665	CcSEcCtD
Acetylcysteine—Urticaria—Simvastatin—atherosclerosis	0.000442	0.00665	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000441	0.00664	CcSEcCtD
Acetylcysteine—Body temperature increased—Simvastatin—atherosclerosis	0.00044	0.00662	CcSEcCtD
Acetylcysteine—Hypersensitivity—Lovastatin—atherosclerosis	0.000439	0.00659	CcSEcCtD
Acetylcysteine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00043	0.00647	CcSEcCtD
Acetylcysteine—Pruritus—Lovastatin—atherosclerosis	0.000421	0.00633	CcSEcCtD
Acetylcysteine—Nausea—Rosuvastatin—atherosclerosis	0.000417	0.00627	CcSEcCtD
Acetylcysteine—Pruritus—Ezetimibe—atherosclerosis	0.000413	0.00621	CcSEcCtD
Acetylcysteine—Hypersensitivity—Simvastatin—atherosclerosis	0.00041	0.00617	CcSEcCtD
Acetylcysteine—Urticaria—Niacin—atherosclerosis	0.000406	0.00611	CcSEcCtD
Acetylcysteine—Body temperature increased—Niacin—atherosclerosis	0.000404	0.00608	CcSEcCtD
Acetylcysteine—Urticaria—Pravastatin—atherosclerosis	0.0004	0.00601	CcSEcCtD
Acetylcysteine—Body temperature increased—Pravastatin—atherosclerosis	0.000398	0.00598	CcSEcCtD
Acetylcysteine—Pruritus—Simvastatin—atherosclerosis	0.000394	0.00592	CcSEcCtD
Acetylcysteine—Dizziness—Lovastatin—atherosclerosis	0.000394	0.00592	CcSEcCtD
Acetylcysteine—Dizziness—Ezetimibe—atherosclerosis	0.000386	0.0058	CcSEcCtD
Acetylcysteine—Vomiting—Lovastatin—atherosclerosis	0.000378	0.00569	CcSEcCtD
Acetylcysteine—Hypersensitivity—Niacin—atherosclerosis	0.000377	0.00566	CcSEcCtD
Acetylcysteine—Rash—Lovastatin—atherosclerosis	0.000375	0.00564	CcSEcCtD
Acetylcysteine—Dermatitis—Lovastatin—atherosclerosis	0.000375	0.00564	CcSEcCtD
Acetylcysteine—Vomiting—Ezetimibe—atherosclerosis	0.000371	0.00558	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pravastatin—atherosclerosis	0.000371	0.00558	CcSEcCtD
Acetylcysteine—Dizziness—Simvastatin—atherosclerosis	0.000368	0.00554	CcSEcCtD
Acetylcysteine—Rash—Ezetimibe—atherosclerosis	0.000368	0.00553	CcSEcCtD
Acetylcysteine—Dermatitis—Ezetimibe—atherosclerosis	0.000368	0.00553	CcSEcCtD
Acetylcysteine—Pruritus—Niacin—atherosclerosis	0.000362	0.00544	CcSEcCtD
Acetylcysteine—Pruritus—Pravastatin—atherosclerosis	0.000356	0.00535	CcSEcCtD
Acetylcysteine—Vomiting—Simvastatin—atherosclerosis	0.000354	0.00532	CcSEcCtD
Acetylcysteine—Nausea—Lovastatin—atherosclerosis	0.000354	0.00532	CcSEcCtD
Acetylcysteine—Rash—Simvastatin—atherosclerosis	0.000351	0.00528	CcSEcCtD
Acetylcysteine—Dermatitis—Simvastatin—atherosclerosis	0.000351	0.00527	CcSEcCtD
Acetylcysteine—Nausea—Ezetimibe—atherosclerosis	0.000347	0.00521	CcSEcCtD
Acetylcysteine—Dizziness—Niacin—atherosclerosis	0.000338	0.00508	CcSEcCtD
Acetylcysteine—Dizziness—Pravastatin—atherosclerosis	0.000333	0.005	CcSEcCtD
Acetylcysteine—Nausea—Simvastatin—atherosclerosis	0.000331	0.00497	CcSEcCtD
Acetylcysteine—Vomiting—Niacin—atherosclerosis	0.000325	0.00489	CcSEcCtD
Acetylcysteine—Rash—Niacin—atherosclerosis	0.000322	0.00485	CcSEcCtD
Acetylcysteine—Dermatitis—Niacin—atherosclerosis	0.000322	0.00484	CcSEcCtD
Acetylcysteine—Vomiting—Pravastatin—atherosclerosis	0.00032	0.00481	CcSEcCtD
Acetylcysteine—Rash—Pravastatin—atherosclerosis	0.000317	0.00477	CcSEcCtD
Acetylcysteine—Dermatitis—Pravastatin—atherosclerosis	0.000317	0.00477	CcSEcCtD
Acetylcysteine—Nausea—Niacin—atherosclerosis	0.000304	0.00457	CcSEcCtD
Acetylcysteine—Nausea—Pravastatin—atherosclerosis	0.000299	0.0045	CcSEcCtD
Acetylcysteine—CHUK—connective tissue—atherosclerosis	0.000288	0.118	CbGeAlD
Acetylcysteine—CHUK—cardiovascular system—atherosclerosis	0.000251	0.103	CbGeAlD
Acetylcysteine—ACY1—liver—atherosclerosis	0.000224	0.0921	CbGeAlD
Acetylcysteine—CHUK—adipose tissue—atherosclerosis	0.000221	0.0907	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—atherosclerosis	0.000196	0.0803	CbGeAlD
Acetylcysteine—SLC7A11—adipose tissue—atherosclerosis	0.000182	0.0747	CbGeAlD
Acetylcysteine—IKBKB—cardiovascular system—atherosclerosis	0.00017	0.0699	CbGeAlD
Acetylcysteine—GSS—cardiovascular system—atherosclerosis	0.000167	0.0686	CbGeAlD
Acetylcysteine—CHUK—liver—atherosclerosis	0.000155	0.0636	CbGeAlD
Acetylcysteine—IKBKB—adipose tissue—atherosclerosis	0.00015	0.0616	CbGeAlD
Acetylcysteine—GSS—adipose tissue—atherosclerosis	0.000147	0.0605	CbGeAlD
Acetylcysteine—IKBKB—liver—atherosclerosis	0.000105	0.0432	CbGeAlD
Acetylcysteine—GSS—liver—atherosclerosis	0.000103	0.0424	CbGeAlD
Acetylcysteine—SLCO1B1—liver—atherosclerosis	7.6e-05	0.0312	CbGeAlD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—atherosclerosis	2.04e-05	0.000129	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.03e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—STAT3—atherosclerosis	2.03e-05	0.000128	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PLA2G1B—atherosclerosis	2.01e-05	0.000127	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MAPK3—atherosclerosis	2.01e-05	0.000127	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—IL6—atherosclerosis	2e-05	0.000127	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—atherosclerosis	2e-05	0.000126	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—atherosclerosis	2e-05	0.000126	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—STAT3—atherosclerosis	1.99e-05	0.000126	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.99e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—atherosclerosis	1.98e-05	0.000125	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.97e-05	0.000125	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—UTS2—atherosclerosis	1.97e-05	0.000125	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.97e-05	0.000125	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—atherosclerosis	1.97e-05	0.000124	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40—atherosclerosis	1.97e-05	0.000124	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR2—atherosclerosis	1.97e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.96e-05	0.000124	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MAPK3—atherosclerosis	1.96e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD14—atherosclerosis	1.95e-05	0.000124	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TGFB1—atherosclerosis	1.95e-05	0.000123	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALOX5—atherosclerosis	1.95e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CNR2—atherosclerosis	1.94e-05	0.000123	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—MAPK3—atherosclerosis	1.94e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—atherosclerosis	1.93e-05	0.000122	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—atherosclerosis	1.93e-05	0.000122	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ICAM1—atherosclerosis	1.92e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MAPK3—atherosclerosis	1.91e-05	0.000121	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TGFB1—atherosclerosis	1.9e-05	0.00012	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CX3CR1—atherosclerosis	1.89e-05	0.00012	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASR—atherosclerosis	1.89e-05	0.00012	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—atherosclerosis	1.89e-05	0.000119	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—VCAM1—atherosclerosis	1.89e-05	0.000119	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.87e-05	0.000118	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CX3CL1—atherosclerosis	1.86e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	1.84e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SOCS3—atherosclerosis	1.83e-05	0.000116	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—atherosclerosis	1.82e-05	0.000115	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.8e-05	0.000114	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD14—atherosclerosis	1.77e-05	0.000112	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—atherosclerosis	1.77e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR2—atherosclerosis	1.76e-05	0.000111	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—atherosclerosis	1.75e-05	0.000111	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—atherosclerosis	1.75e-05	0.00011	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NAMPT—atherosclerosis	1.74e-05	0.00011	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.73e-05	0.00011	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LIPC—atherosclerosis	1.73e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VWF—atherosclerosis	1.73e-05	0.000109	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOC3—atherosclerosis	1.72e-05	0.000109	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOC3—atherosclerosis	1.72e-05	0.000109	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LDLR—atherosclerosis	1.71e-05	0.000108	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—VCAM1—atherosclerosis	1.71e-05	0.000108	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LDLR—atherosclerosis	1.71e-05	0.000108	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CETP—atherosclerosis	1.67e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL18—atherosclerosis	1.67e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL3—atherosclerosis	1.67e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD40LG—atherosclerosis	1.66e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SOCS3—atherosclerosis	1.66e-05	0.000105	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.63e-05	0.000103	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AGER—atherosclerosis	1.6e-05	0.000101	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SCARB1—atherosclerosis	1.6e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NCF1—atherosclerosis	1.6e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PRKCG—atherosclerosis	1.59e-05	0.0001	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOB—atherosclerosis	1.58e-05	9.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VWF—atherosclerosis	1.57e-05	9.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—atherosclerosis	1.56e-05	9.88e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.56e-05	9.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOC3—atherosclerosis	1.56e-05	9.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD36—atherosclerosis	1.55e-05	9.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LDLR—atherosclerosis	1.55e-05	9.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—atherosclerosis	1.54e-05	9.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL18—atherosclerosis	1.51e-05	9.57e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMGCR—atherosclerosis	1.51e-05	9.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL3—atherosclerosis	1.51e-05	9.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR2—atherosclerosis	1.51e-05	9.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDNRA—atherosclerosis	1.51e-05	9.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40LG—atherosclerosis	1.51e-05	9.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—LPL—atherosclerosis	1.51e-05	9.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CYBA—atherosclerosis	1.5e-05	9.5e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.48e-05	9.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLAT—atherosclerosis	1.47e-05	9.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GHRL—atherosclerosis	1.47e-05	9.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PARP1—atherosclerosis	1.47e-05	9.3e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—atherosclerosis	1.47e-05	9.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PRKCG—atherosclerosis	1.46e-05	9.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AGER—atherosclerosis	1.45e-05	9.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NCF1—atherosclerosis	1.45e-05	9.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PRKCG—atherosclerosis	1.44e-05	9.1e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—atherosclerosis	1.43e-05	9.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PDGFB—atherosclerosis	1.43e-05	9.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—atherosclerosis	1.42e-05	8.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—atherosclerosis	1.42e-05	8.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD36—atherosclerosis	1.41e-05	8.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—atherosclerosis	1.4e-05	8.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NFKB1—atherosclerosis	1.4e-05	8.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—atherosclerosis	1.39e-05	8.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK8—atherosclerosis	1.37e-05	8.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR2—atherosclerosis	1.37e-05	8.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDNRA—atherosclerosis	1.37e-05	8.65e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.36e-05	8.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CYBA—atherosclerosis	1.36e-05	8.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—atherosclerosis	1.36e-05	8.58e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—atherosclerosis	1.35e-05	8.56e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ABCA1—atherosclerosis	1.35e-05	8.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NFKB1—atherosclerosis	1.34e-05	8.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TLR4—atherosclerosis	1.34e-05	8.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PARP1—atherosclerosis	1.33e-05	8.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GHRL—atherosclerosis	1.33e-05	8.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLAT—atherosclerosis	1.33e-05	8.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PDGFB—atherosclerosis	1.32e-05	8.35e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—atherosclerosis	1.32e-05	8.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PDGFB—atherosclerosis	1.3e-05	8.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KNG1—atherosclerosis	1.29e-05	8.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—atherosclerosis	1.29e-05	8.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ICAM1—atherosclerosis	1.28e-05	8.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AGTR1—atherosclerosis	1.28e-05	8.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—atherosclerosis	1.27e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NFKB1—atherosclerosis	1.27e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—atherosclerosis	1.26e-05	7.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CAV1—atherosclerosis	1.25e-05	7.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLG—atherosclerosis	1.25e-05	7.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOA1—atherosclerosis	1.25e-05	7.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK8—atherosclerosis	1.24e-05	7.87e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NFKB1—atherosclerosis	1.22e-05	7.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR4—atherosclerosis	1.21e-05	7.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK3—atherosclerosis	1.2e-05	7.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SOCS3—atherosclerosis	1.18e-05	7.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS2—atherosclerosis	1.18e-05	7.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KNG1—atherosclerosis	1.17e-05	7.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ICAM1—atherosclerosis	1.16e-05	7.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGTR1—atherosclerosis	1.16e-05	7.35e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMOX1—atherosclerosis	1.16e-05	7.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP3—atherosclerosis	1.14e-05	7.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF2—atherosclerosis	1.14e-05	7.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLG—atherosclerosis	1.13e-05	7.17e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOB—atherosclerosis	1.11e-05	7.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOB—atherosclerosis	1.1e-05	6.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDN1—atherosclerosis	1.09e-05	6.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK3—atherosclerosis	1.09e-05	6.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL5—atherosclerosis	1.08e-05	6.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—INS—atherosclerosis	1.08e-05	6.82e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—atherosclerosis	1.08e-05	6.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SOCS3—atherosclerosis	1.07e-05	6.79e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LPL—atherosclerosis	1.06e-05	6.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LPL—atherosclerosis	1.05e-05	6.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP3—atherosclerosis	1.04e-05	6.55e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—atherosclerosis	1.03e-05	6.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF2—atherosclerosis	1.03e-05	6.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKCG—atherosclerosis	1.03e-05	6.49e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CD36—atherosclerosis	1.01e-05	6.36e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—atherosclerosis	1e-05	6.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOB—atherosclerosis	1e-05	6.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SPP1—atherosclerosis	9.99e-06	6.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SERPINE1—atherosclerosis	9.91e-06	6.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDN1—atherosclerosis	9.86e-06	6.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL5—atherosclerosis	9.78e-06	6.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—atherosclerosis	9.77e-06	6.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LPL—atherosclerosis	9.57e-06	6.05e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—atherosclerosis	9.53e-06	6.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—atherosclerosis	9.46e-06	5.98e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARA—atherosclerosis	9.35e-06	5.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCG—atherosclerosis	9.3e-06	5.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFB—atherosclerosis	9.24e-06	5.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SPP1—atherosclerosis	9.06e-06	5.73e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AGT—atherosclerosis	9.05e-06	5.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AGT—atherosclerosis	9.02e-06	5.71e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—atherosclerosis	8.87e-06	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—atherosclerosis	8.86e-06	5.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—atherosclerosis	8.84e-06	5.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—atherosclerosis	8.84e-06	5.59e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAV1—atherosclerosis	8.79e-06	5.56e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOA1—atherosclerosis	8.77e-06	5.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—atherosclerosis	8.77e-06	5.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CAV1—atherosclerosis	8.76e-06	5.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOA1—atherosclerosis	8.74e-06	5.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—atherosclerosis	8.72e-06	5.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—atherosclerosis	8.65e-06	5.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—atherosclerosis	8.44e-06	5.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFB—atherosclerosis	8.38e-06	5.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—F2—atherosclerosis	8.34e-06	5.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGT—atherosclerosis	8.18e-06	5.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFKB1—atherosclerosis	8.13e-06	5.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—atherosclerosis	8.09e-06	5.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—atherosclerosis	8.02e-06	5.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—atherosclerosis	8.02e-06	5.07e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	8e-06	5.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK8—atherosclerosis	7.99e-06	5.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—atherosclerosis	7.98e-06	5.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—atherosclerosis	7.95e-06	5.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CAV1—atherosclerosis	7.94e-06	5.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOA1—atherosclerosis	7.93e-06	5.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—atherosclerosis	7.91e-06	5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—atherosclerosis	7.76e-06	4.91e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—atherosclerosis	7.73e-06	4.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—atherosclerosis	7.65e-06	4.84e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—INS—atherosclerosis	7.58e-06	4.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—F2—atherosclerosis	7.56e-06	4.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—INS—atherosclerosis	7.55e-06	4.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—atherosclerosis	7.43e-06	4.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFKB1—atherosclerosis	7.37e-06	4.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—atherosclerosis	7.33e-06	4.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—atherosclerosis	7.31e-06	4.62e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—atherosclerosis	7.31e-06	4.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK8—atherosclerosis	7.25e-06	4.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—atherosclerosis	7.24e-06	4.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—atherosclerosis	7.04e-06	4.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—atherosclerosis	6.98e-06	4.42e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—atherosclerosis	6.95e-06	4.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SERPINE1—atherosclerosis	6.94e-06	4.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—INS—atherosclerosis	6.85e-06	4.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—atherosclerosis	6.75e-06	4.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—atherosclerosis	6.74e-06	4.26e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—atherosclerosis	6.64e-06	4.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—atherosclerosis	6.63e-06	4.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—atherosclerosis	6.63e-06	4.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—atherosclerosis	6.62e-06	4.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—atherosclerosis	6.45e-06	4.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—atherosclerosis	6.33e-06	4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SERPINE1—atherosclerosis	6.29e-06	3.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—atherosclerosis	6.26e-06	3.96e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	6.08e-06	3.84e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—atherosclerosis	6.01e-06	3.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—atherosclerosis	5.88e-06	3.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—atherosclerosis	5.33e-06	3.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—atherosclerosis	5.31e-06	3.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKB1—atherosclerosis	5.26e-06	3.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK8—atherosclerosis	5.17e-06	3.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—atherosclerosis	5.11e-06	3.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—atherosclerosis	4.82e-06	3.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—atherosclerosis	4.77e-06	3.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKB1—atherosclerosis	4.77e-06	3.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—atherosclerosis	4.73e-06	2.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—atherosclerosis	4.71e-06	2.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—atherosclerosis	4.71e-06	2.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK8—atherosclerosis	4.69e-06	2.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—atherosclerosis	4.63e-06	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—atherosclerosis	4.51e-06	2.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—atherosclerosis	4.38e-06	2.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—atherosclerosis	4.35e-06	2.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—atherosclerosis	4.33e-06	2.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—atherosclerosis	4.28e-06	2.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—atherosclerosis	4.27e-06	2.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—atherosclerosis	4.09e-06	2.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—atherosclerosis	3.97e-06	2.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—atherosclerosis	3.3e-06	2.09e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—atherosclerosis	3.05e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—atherosclerosis	3.05e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—atherosclerosis	2.99e-06	1.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—atherosclerosis	2.76e-06	1.75e-05	CbGpPWpGaD
